Vantage Consulting Group’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,211
Closed -$14K 217
2022
Q3
$14K Sell
14,211
-20,280
-59% -$32.5K 0.01% 212
2022
Q2
$63K Buy
34,491
+8,960
+35% +$20.5K 0.04% 207
2022
Q1
$82K Sell
25,531
-5,037
-16% -$15.4K 0.03% 210
2021
Q4
$94K Buy
30,568
+5,485
+22% +$17.7K 0.03% 227
2021
Q3
$85K Buy
25,083
+2,346
+10% +$8.85K 0.02% 201
2021
Q2
$95K Buy
22,737
+6,692
+42% +$27.6K 0.02% 207
2021
Q1
$77K Buy
16,045
+292
+2% +$1.34K 0.02% 97
2020
Q4
$65K Buy
+15,753
New +$62.1K 0.01% 349

Other funds holding DHC

Vantage Consulting Group's DHC Position: Q4 2022 in Review

Vantage Consulting Group sold out of Diversified Healthcare Trust (DHC) in Q4 2022, closing a stake of 14,211 shares — an estimated $14K sold.

Vantage Consulting Group first reported a position in DHC in Q4 2020 and held it in 8 quarters. The position peaked at $95K in Q2 2021. 182 funds tracked by Wall St. Rank hold DHC as of Q4 2022.

  • Vantage Consulting Group reported no remaining Diversified Healthcare Trust position as of Q4 2022 after selling out during the quarter.
  • Vantage Consulting Group sold 14,211 Diversified Healthcare Trust shares in Q4 2022, an estimated $14K.
  • Vantage Consulting Group first reported a position in Diversified Healthcare Trust in Q4 2020 and held it in 8 quarters.
  • Vantage Consulting Group's Diversified Healthcare Trust position peaked at $95K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q4 2022.

Based on Vantage Consulting Group's 13F filing for Q4 2022, filed 13 Feb 2023.